Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Operating Leases (2019 - 2025)

Lemaitre Vascular (LMAT) has disclosed Operating Leases for 7 consecutive years, with $14.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Leases fell 8.07% to $14.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.0 million, a 8.07% decrease, with the full-year FY2025 number at $14.0 million, down 8.07% from a year prior.
  • Operating Leases was $14.0 million for Q4 2025 at Lemaitre Vascular, down from $17.2 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $18.9 million in Q1 2024 to a low of $13.7 million in Q1 2022.
  • A 5-year average of $15.8 million and a median of $15.2 million in 2021 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: surged 30.69% in 2024, then dropped 21.93% in 2025.
  • Lemaitre Vascular's Operating Leases stood at $14.1 million in 2021, then increased by 4.57% to $14.7 million in 2022, then rose by 13.01% to $16.6 million in 2023, then fell by 8.37% to $15.2 million in 2024, then dropped by 8.07% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Operating Leases are $14.0 million (Q4 2025), $17.2 million (Q3 2025), and $14.9 million (Q2 2025).